Show simple item record

dc.contributor.authorNdjeka, N
dc.contributor.authorConradie, F
dc.contributor.authorSchnippel, K
dc.contributor.authorHughes, J
dc.contributor.authorBantubani, N
dc.contributor.authorFerreira, H
dc.contributor.authorMaartens, G
dc.contributor.authorMametja, D
dc.contributor.authorMeintjes, G
dc.contributor.authorPadanilam, X
dc.contributor.authorVariava, E
dc.contributor.authorPym, A
dc.contributor.authorPillay, Y
dc.date.accessioned2015-07-21T22:48:23Z
dc.date.available2015-07-21T22:48:23Z
dc.date.issued2015-08-01
dc.identifier.citationTreatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. 2015, 19 (8):979-85 Int. J. Tuberc. Lung Dis.en_GB
dc.identifier.issn1815-7920
dc.identifier.pmid26162365
dc.identifier.doi10.5588/ijtld.14.0944
dc.identifier.urihttp://hdl.handle.net/10144/560845
dc.description.abstractSouth Africa has a large burden of extensively drug-resistant tuberculosis (XDR-TB); only 15% of XDR-TB patients have successful outcomes.
dc.language.isoenen
dc.publisherInternational Union Against Tuberculosis and Lung Diseaseen_GB
dc.rightsArchived with thanks to The International Journal of Tuberculosis and Lung Disease : the official journal of the International Union against Tuberculosis and Lung Diseaseen_GB
dc.titleTreatment of Drug-resistant Tuberculosis with Bedaquiline in a High HIV Prevalence Setting: An Interim Cohort Analysisen
dc.identifier.journalInternational Journal of Tuberculosis and Lung Diseaseen_GB
refterms.dateFOA2019-03-04T12:30:55Z
html.description.abstractSouth Africa has a large burden of extensively drug-resistant tuberculosis (XDR-TB); only 15% of XDR-TB patients have successful outcomes.


Files in this item

Thumbnail
Name:
Ndjeka N et al - 2015 - Treatment ...
Size:
540.2Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record